Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM2 | Q00987 | 6/20 | 0.57 |
| ▸ | MDM4 | O15151 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | TGM2 | P21980 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL436024 | 1.00 | MDM2 (0.57) | MDM2MDM4TP53TLR2KMT2A | |
| SCHEMBL29547181 | 1.00 | MDM2 (0.57) | MDM2MDM4TP53TLR2KMT2A | |
| SCHEMBL2288397 | 1.00 | MDM2 (0.57) | MDM2MDM4TP53TLR2KMT2A | |
| SCHEMBL29792115 | 1.00 | MDM2 (0.57) | MDM2MDM4TP53TLR2KMT2A | |
| SCHEMBL31681399 | 1.00 | MDM2 (0.57) | MDM2MDM4TP53TLR2KMT2A | |
| SCHEMBL29362301 | 1.00 | MDM2 (0.57) | MDM2MDM4TP53TLR2KMT2A | |
| SCHEMBL21192401 | 0.97 | MDM2 (0.58) | MDM2MDM4TP53TLR2KMT2A | |
| SCHEMBL5967470 | 0.97 | MDM2 (0.58) | MDM2MDM4TP53TLR2KMT2A | |
| SCHEMBL29401280 | 0.97 | MDM2 (0.58) | MDM2MDM4TP53TLR2KMT2A | |
| SCHEMBL31614333 | 0.94 | MDM2 (0.53) | MDM2MDM4TP53TLR2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110054664-B | Side chain fatty acid modified antibacterial peptide analogue containing D-type amino acid and synthesis and application thereof | 倪京满 | 2023-05-26 | — | — | CN | claimed |
| CN-118812662-A | Method for preparing ganirelix acetate | 杭州昊肽生物科技有限公司 | 2024-10-22 | — | — | CN | disclosed |
| EP-3027228-B1 | MODULAR IMAGING AGENTS CONTAINING AMINO ACIDS AND PEPTIDES | ROCHESTER INSTITUTE TECH (US) | 2024-10-02 | — | — | EP | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-20240209034-A1 | ENGINEERING PEPTIDES FOR A A VB6 INTEGRIN BINDING AND RELATED METHODS OF USE AND SYNTHESIS | UNIV WASHINGTON (US) | 2024-06-27 | — | — | US | disclosed |
| WO-2024081824-A2 | SYNTHETIC INTERMEDIATES FOR UNIVERSAL CHIMERIC ANTIGEN RECEPTOR IMMUNE CELL THERAPIES | UNIVERSITY OF WASHINGTON (US) | 2024-04-18 | — | — | WO | disclosed |
| CN-114401749-B | Radionuclide marker and application thereof | 北京拓界生物医药科技有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| US-11674136-B2 | DNA-templated macrocycle library | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-06-13 | — | — | US | disclosed |
| CN-110054664-B | Side chain fatty acid modified antibacterial peptide analogue containing D-type amino acid and synthesis and application thereof | 倪京满 | 2023-05-26 | — | — | CN | disclosed |
| WO-2022221144-A9 | ENGINEERED PEPTIDES FOR ΑVΒ6 INTEGRIN BINDING AND RELATED METHODS OF USE AND SYNTHESIS | UNIVERSITY OF WASHINGTON (US) | 2023-05-19 | — | — | WO | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| WO-2022221144-A1 | ENGINEERED PEPTIDES FOR ΑVΒ6 INTEGRIN BINDING AND RELATED METHODS OF USE AND SYNTHESIS | UNIVERSITY OF WASHINGTON (US) | 2022-10-20 | — | — | WO | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| CN-114401749-A | Radionuclide marker and application thereof | 北京拓界生物医药科技有限公司 | 2022-04-26 | — | — | CN | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
| EP-1504094-A2 | PEPTIDE COMPOUNDS AND THEIR USE AS PROTEASE SUBSTRATES | Pharmacia Corporation (US) | 2005-02-09 | — | — | EP | disclosed |
| US-20040018561-A1 | Peptide compounds and their use as protease substrates | PHARMACIA CORPORATION | 2004-01-29 | — | — | US | disclosed |
| WO-2003095475-A2 | PEPTIDE COMPOUNDS AND THEIR USE AS PROTEASE SUBSTRATES | PHARMACIA CORPORATION (US) | 2003-11-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11674136-B2 | DNA-templated macrocycle library | IDE, IAPP, POLRMT | MDM2 938/4885MDM4 1827/4885TP53 130/4885 |
| US-20040018561-A1 | Peptide compounds and their use as protease substrates | MMP3, MMP25, MMP11 | MDM2 1389/4885MDM4 1345/4885TP53 478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.